2014
DOI: 10.3762/bjnano.5.52
|View full text |Cite
|
Sign up to set email alerts
|

The softening of human bladder cancer cells happens at an early stage of the malignancy process

Abstract: SummaryVarious studies have demonstrated that alterations in the deformability of cancerous cells are strongly linked to the actin cytoskeleton. By using atomic force microscopy (AFM), it is possible to determine such changes in a quantitative way in order to distinguish cancerous from non-malignant cells. In the work presented here, the elastic properties of human bladder cells were determined by means of AFM. The measurements show that non-malignant bladder HCV29 cells are stiffer (higher Young’s modulus) th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
91
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 103 publications
(107 citation statements)
references
References 35 publications
16
91
0
Order By: Relevance
“…Thus, due to the differences in microenvironments, cells derived from normal tissues and tumors are intrinsically different in their stiffness, which allows Young's modulus to be a reliable biomarker in the evaluation of metastasis and the motility of cells. In addition, the morphological observations support this opinion experimentally, showing that the cancerous cells usually have decreased stress fibers [25,29,33,67,68], increased cortical actin [25,33], and more lamellipodia [26,65], which benefit the invasion of cells by decreasing adhesion with the substrate and increasing the contraction forces for deformation and protrusion [27,64]. Taking into account that the nuclei are usually softer in cells with higher motility [58] and that the cortex actin network is much softer than the stress fibers [41], it is reasonable to detect a lower Young's modulus in metastatic carcinoma cells.…”
Section: Data Volumesupporting
confidence: 52%
See 1 more Smart Citation
“…Thus, due to the differences in microenvironments, cells derived from normal tissues and tumors are intrinsically different in their stiffness, which allows Young's modulus to be a reliable biomarker in the evaluation of metastasis and the motility of cells. In addition, the morphological observations support this opinion experimentally, showing that the cancerous cells usually have decreased stress fibers [25,29,33,67,68], increased cortical actin [25,33], and more lamellipodia [26,65], which benefit the invasion of cells by decreasing adhesion with the substrate and increasing the contraction forces for deformation and protrusion [27,64]. Taking into account that the nuclei are usually softer in cells with higher motility [58] and that the cortex actin network is much softer than the stress fibers [41], it is reasonable to detect a lower Young's modulus in metastatic carcinoma cells.…”
Section: Data Volumesupporting
confidence: 52%
“…A close correlation between actin filaments and cell stiffness has been demonstrated by the use of disruptive pharmacological agents, such as cytochalasin D [28,29], latrunculin A [10], and latrunculin B [30,31]. The dissolution of the actin cytoskeleton led to a significant decrease in Young's modulus,…”
Section: Actin Filamentsmentioning
confidence: 95%
“…25,26 Several experiments have demonstrated the existence of viscous processes in the cytoskeleton remodeling and in the inner cell dynamics. [26][27][28] In fact, stiffness measurements performed on cancer cells of different pathological degrees 17,29,30 have given similar elastic (Young) moduli values. These findings could be related to the limitations of stiffness measurements to describe the mechanical state of a cell.…”
Section: Introductionmentioning
confidence: 99%
“…Ramos et al [20] investigated the elastic properties of non-malignant and cancerous bladder cell lines using the AFM. They found that normal cells are stiffer than cancer cells.…”
Section: Mechanical Properties Are a Marker Of Cancer Cell Invasivitymentioning
confidence: 99%